Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared insights into the company’s latest strategic moves in the Asia-Pacific region. With newly signed MOUs in South Korea, Avance Clinical aims to enhance its site relationships and leverage the country’s advanced healthcare infrastructure to support high-quality, expedited clinical trials. Lungershausen discussed the significance of these partnerships, the benefits for early-phase biotech clients, and how Avance Clinical plans to navigate the evolving regulatory landscape while prioritizing key therapeutic areas like oncology and rare diseases.

Read the full article